T1	Entity 143 153	secretases
T2	Entity 167 189	amyloid-β (Aβ) peptide
T3	Entity 199 230	amyloid precursor protein (APP)
T4	Entity 318 335	Alzheimer disease
T5	KeyEntity 375 388	Aβ production
T6	Entity 396 401	brain
T7	Entity 550 565	amyloid lesions
T8	Entity 132 141	proteases
R1	is_subclass_of Arg1:T1 Arg2:T8	
R2	interacts_with Arg1:T8 Arg2:T2	
R3	is_part_of Arg1:T2 Arg2:T3	
T9	Entity 730 752	transgenic mouse model
T10	Entity 791 804	Aβ production
T11	Entity 834 854	secretase inhibitors
T12	Entity 862 866	mice
T13	KeyEntity 879 889	mutant APP
R4	other_relation Arg1:T12 Arg2:T13	
#1	AnnotatorNotes R4	express
T14	KeyEntity 929 940	doxycycline
R5	regulates Arg1:T14 Arg2:T12	
T15	Entity 967 988;992 995	high-level expression APP
T16	Entity 1674 1689	amyloid lesions
T17	Entity 1693 1708	transgenic mice
R6	is_part_of Arg1:T16 Arg2:T17	
T18	Entity 1803 1826	arresting Aβ production
T19	Entity 1830 1861	patients with Alzheimer disease
T20	Entity 1967 1983	amyloid deposits
R7	participates_in Arg1:T18 Arg2:T19	
T21	Entity 1012 1039	fulminant amyloid pathology
T22	KeyEntity 1054 1080	doxycycline administration
T23	Entity 1090 1115	transgenic APP expression
T24	Entity 1148 1161	Aβ production
T25	Entity 1216 1239	transgenic Aβ synthesis
T26	Entity 1348 1364	amyloid deposits
T27	Entity 1474 1487	APP synthesis
T28	Entity 1546 1557	Aβ deposits
T29	Entity 1580 1593	amyloid load,
R8	participates_in Arg1:T15 Arg2:T21	
R9	regulates Arg1:T22 Arg2:T23	
R10	interacts_with Arg1:T22 Arg2:T24	
T30	Entity 1181 1199	nontransgenic mice
T31	Entity 1273 1305	progression of amyloid pathology
R11	regulates Arg1:T25 Arg2:T31	
T32	Entity 1720 1737	stable structures
R12	regulates Arg1:T32 Arg2:T16	
#2	AnnotatorNotes R12	attribute
